Fingerprint
Dive into the research topics of 'Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing
Peter U. Fischer, Kerstin Fischer, Kurt C. Curtis, Yuefang Huang, Nicole Fetcho, Charles W. Goss, Gary J. Weil
- Division of Infectious Diseases
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute for Public Health
- Institute of Clinical and Translational Sciences (ICTS)
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- COVID-19 Researchers
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Evolution, Ecology and Population Biology
- Global Health Center (GHC)
- Center for Biostatistics and Data Science (CBDS)
- DBBS - Biomedical Informatics and Data Science
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations